Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization

被引:24
|
作者
Simon, Aaron [1 ]
Harrington, Elizabeth O. [1 ,2 ]
Liu, Gong Xin [2 ]
Koren, Gideon [2 ]
Choudhary, Gaurav [1 ,2 ]
机构
[1] Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02908 USA
[2] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA
关键词
large-conductance calcium-activated potassium channels; ion channel; SMOOTH-MUSCLE CELLS; PULMONARY-HYPERTENSION; POTASSIUM CHANNELS; CA2+ SENSITIVITY; GAP-JUNCTIONS; BKCA CHANNEL; ION CHANNELS; CGMP; CONDUCTANCE; ARTERIES;
D O I
10.1152/ajplung.90303.2008
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Simon A, Harrington EO, Liu GX, Koren G, Choudhary G. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization. Am J Physiol Lung Cell Mol Physiol 296: L248-L256, 2009. First published November 26, 2008; doi:10.1152/ajplung.90303.2008.-C-type natriuretic peptide (CNP) has a demonstrated hyperpolarizing effect on vascular smooth muscle cells. However, its autocrine function, including its electrophysiological effect on endothelial cells, is not known. Here, we report the effect of CNP on the membrane potential (E-m) of pulmonary microvascular endothelial cells and describe its target receptors, second messengers, and ion channels. We measured changes in E-m using fluorescence imaging and perforated patch-clamping techniques. In imaging experiments, samples were preincubated in the potentiometric dye DiBAC(4)(3), and subsequently exposed to CNP in the presence of selective inhibitors of ion channels or second messengers. CNP exposure induced a dose-dependent decrease in fluorescence, indicating that CNP induces endothelial cell hyperpolarization. CNP-induced hyperpolarization was inhibited by the K+ channel blockers, tetraethylammonium or iberiotoxin, the nonspecific cation channel blocker, La3+, or by depletion or repletion of extracellular Ca2+ or K+, respectively. CNP-induced hyperpolarization was also blocked by pharmacological inhibition of PKG or by small interfering RNA (siRNA)-mediated knockdown of natriuretic peptide receptor-B (NPR-B). CNP-induced hyperpolarization was mimicked by the PKG agonist, 8-bromo-cGMP, and attenuated by both the endothelial nitric oxide synthase ( eNOS) inhibitor, N-omega-nitro-L-arginine methyl ester (L-NAME), and the soluble guanylyl cyclase (sGC) inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Presence of iberiotoxin-sensitive, CNP-induced outward current was confirmed by perforated patch-clamping experiments. We conclude that CNP hyperpolarizes pulmonary microvascular endothelial cells by activating large-conductance calcium-activated potassium channels mediated by the activation of NPR-B, PKG, eNOS, and sGC.
引用
收藏
页码:L248 / L256
页数:9
相关论文
共 50 条
  • [31] Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion
    Doi, K
    Itoh, H
    Komatsu, Y
    Igaki, T
    Chun, TH
    Takaya, K
    Yamashita, J
    Inoue, M
    Yoshimasa, T
    Nakao, K
    HYPERTENSION, 1996, 27 (03) : 811 - 815
  • [32] Endothelial C-Type Natriuretic Peptide Is a Critical Regulator of Angiogenesis and Vascular Remodeling
    Bubb, Kristen J.
    Aubdool, Aisah A.
    Moyes, Amie J.
    Lewis, Sarah
    Drayton, Jonathan P.
    Tang, Owen
    Mehta, Vedanta
    Zachary, Ian C.
    Abraham, David J.
    Tsui, Janice
    Hobbs, Adrian J.
    CIRCULATION, 2019, 139 (13) : 1612 - 1628
  • [33] CLEARANCE RECEPTOR MECHANISMS IN THE REGULATION OF THE ENDOTHELIAL CELL-DERIVED VASOACTIVE C-TYPE NATRIURETIC PEPTIDE
    BRANDT, RR
    AARHUS, LL
    LEWICKI, JA
    BURNETT, JC
    CIRCULATION, 1993, 88 (04) : 182 - 182
  • [34] Endothelin-3 reduces C-type natriuretic peptide-induced cyclic GMP formation in C6 glioma cells
    Tsang, D
    Tung, CSY
    Yeung, VTF
    Cockram, CS
    REGULATORY PEPTIDES, 1997, 70 (2-3) : 91 - 96
  • [35] Regulation of endothelial production of C-type natriuretic peptide by interaction between endothelial cells and macrophages
    Suga, S
    Itoh, H
    Komatsu, Y
    Ishida, H
    Igaki, T
    Yamashita, J
    Doi, K
    Chun, TH
    Yoshimasa, T
    Tanaka, I
    Nakao, K
    ENDOCRINOLOGY, 1998, 139 (04) : 1920 - 1926
  • [36] C-Type Natriuretic Peptide and Cardiac Fibrosis
    Richards, A. Mark
    HYPERTENSION, 2011, 57 (02) : 154 - 155
  • [37] Regulation of C-type natriuretic peptide expression
    Sellitti, Donald F.
    Koles, Nancy
    Mendonca, Maria C.
    PEPTIDES, 2011, 32 (09) : 1964 - 1971
  • [38] C-type natriuretic peptide in prostate cancer
    Nielsen, Soeren Junge
    Iversen, Peter
    Rehfeld, Jens F.
    Jensen, Helle Lone
    Goetze, Jens Peter
    APMIS, 2009, 117 (01) : 60 - 67
  • [39] C-type natriuretic peptide and heart failure
    Del Ry, Silvia
    Passino, Claudio
    Emdin, Michele
    Giannessi, Daniela
    PHARMACOLOGICAL RESEARCH, 2006, 54 (05) : 326 - 333
  • [40] Ocular hypotension induced by intravitreally injected c-type natriuretic peptide
    Takashima, Y
    Taniguchi, T
    Yoshida, M
    Haque, MSR
    Igaki, T
    Itoh, H
    Nakao, K
    Honda, Y
    Yoshimura, N
    EXPERIMENTAL EYE RESEARCH, 1998, 66 (01) : 89 - 96